Please assess the completion status of the following clinical trial:

Trial Title: European Active Surveillance Study (EURAS)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women starting OC use or women switching OCs~* Women willing to participate in the active surveillance for several years~Exclusion Criteria:~* Women who have contraindications for OC use

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Users of Drospirenone (DRSP) (Type: None): None
- Users of Levonorgestrel (LNG) (Type: None): None
- Users of other oral contraceptives (OCs) (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).